In this study, the authors investigated the role of YAP in breast cancer cells undergoing TGF-β1-induced apoptosis and epithelial-mesenchymal transition (EMT), both of which have been implicated in the resistance of cancer cells to immunotherapy. The gene discussed is YAP1; the disease is breast carcinoma.